ストックスクリーナーアプリを入手
3.9512
0.89%
0.0312
Altimmune Inc (ALT) 最新ニュース
Altimmune (NASDAQ:ALT) Receives Buy Rating from HC Wainwright - MarketBeat
ALT Stock: HC Wainwright & Co. Reiterates 'Buy' Rating with $12 - GuruFocus
Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of “Hold” from Analysts - Defense World
Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Hold" from Analysts - MarketBeat
ALTIMMUNE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Pleasing Signs As A Number Of Insiders Buy Altimmune Stock - Yahoo Finance
PFG Investments LLC Has $46,000 Stock Position in Altimmune, Inc. $ALT - Defense World
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders - Sahm
Investors who lost money on Altimmune, Inc. (ALT) should contact Levi & Korsinsky about pending Class ActionALT - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Business Wire
October 6, 2025 Deadline Approaching: Join Class Action Against Altimmune, Inc. (ALT)Contact Levi & Korsinsky - ACCESS Newswire
ALTIMMUNE FINAL DEADLINE REMINDER: Bragar Eagel & Squire, - GlobeNewswire
Investors in Altimmune, Inc. Should Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your RightsALT - PR Newswire
ALT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - FinancialContent
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025ALT - Newsfile
Join Class Action to Recover Losses from Altimmune, Inc. (ALT)Contact Levi & Korsinsky Before October 6, 2025 - Newsfile
Altimmune Appoints New Chief Medical Officer - TipRanks
ALTIMMUNE CLASS ACTION REMINDER: Bragar Eagel & Squire, - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming DeadlinesALT - WV News
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - MarketScreener
ALT Deadline: ALT Investors with Losses in Excess of $50K Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit - Morningstar
Shareholders that lost money on Altimmune, Inc.(ALT) Urged - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Newsfile
Altimmune, Inc. (NASDAQ: ALT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit - Prime Publishers, Inc.
Securities Lawsuit Alert: Altimmune, Inc. (ALT) InvestorsContact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
Portnoy Law Firm Announces Class Action on Behalf of Altimmune, Inc. Investors - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Altimmune, Inc.Act Now - Nasdaq
Relative strength of Altimmune Inc. in sector analysisPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
ALT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire
Altimmune at Stifel Forum: Strategic Insights on MASH Drug - Investing.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - GlobeNewswire
Altimmune, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – ALT - The Globe and Mail
About Us - FinancialContent
Does Altimmune Inc. qualify in momentum factor screeningStop Loss & Accurate Entry/Exit Alerts - newser.com
Altimmune appoints new chief medical officer to lead pemvidutide program By Investing.com - Investing.com Nigeria
The Gross Law Firm Reminds Altimmune Investors of the - GlobeNewswire
Class Action Lawsuit Filed Against Altimmune, Inc. (ALT)Recover LossesContact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
ALTIMMUNE (ALT) DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securitie - GuruFocus
Using economic indicators to assess Altimmune Inc. potentialPrice Action & Precise Trade Entry Recommendations - newser.com
Altimmune Appoints Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer - citybiz
Can Altimmune Inc. rally from current levels2025 Price Targets & High Return Stock Watch Alerts - newser.com
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class ActionALT - Eastern Progress
Altimmune appoints new chief medical officer to lead pemvidutide program - Investing.com
0.95%
大文字化:
|
ボリューム (24 時間):